Idiosyncratic hepatic toxicity in autosomal dominant polycystic kidney disease (ADPKD) patient in combined treatment with tolvaptan and amoxicillin/clavulanic acid: a case report

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disease characterized by the presence of renal cysts. Over time the expanding cysts lead to progressive renal failure. The use of tolvaptan, a V(2)-receptor antagonist, was recently approved in ADPKD patients. It was de...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellegrino, Angela Maria, Annicchiarico Petruzzelli, Luigi, Riccio, Eleonora, Pisani, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873754/
https://www.ncbi.nlm.nih.gov/pubmed/31752750
http://dx.doi.org/10.1186/s12882-019-1612-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873754/
https://www.ncbi.nlm.nih.gov/pubmed/31752750
http://dx.doi.org/10.1186/s12882-019-1612-7

Ejemplares similares